Dexcom (Nasdaq:DXCM) is a company known as one of the market leaders in continuous glucose monitoring (CGM) technology.
CGMs are a key system for people with diabetes to manage their condition. But, Dexcom has worked to ensure that its CGM technology goes beyond its standalone capabilities.
The Dexcom G6, the company’s previous-generation CGM, integrates with a number of automated insulin delivery systems. Insulet, Tandem Diabetes Care, Beta Bionics and more develop systems that utilize Dexcom CGM.
At the European Association for the Study of Diabetes annual meeting this month, Dexcom shared data highlighting this integration. Results from the COMISAIR seven-year study showed the significant and continued reduction of HbA1c with the use of real-time CGM. On top of that, real-time CGM connected to automated insulin delivery (AID) systems showed further substantial HbA1c reductions. In the case of COMISAIR, participants used the Tandem Diabetes Care Control IQ automated insulin delivery system.
Speaking to Drug Delivery Business News, Dexcom EVP and COO Jake Leach explained the importance of integrating CGM with automated systems, plus more positives from Dexcom’s monitoring technology shared at EASD.
Original article: (https://www.massdevice.com/dexcom-integrates-cgm-automated-insulin-delivery/)